Efficacy, safety, quality control, marketing and regulatory guidelines for herbal medicines (phytotherapeutic agents)
- PMID: 10657057
- DOI: 10.1590/s0100-879x2000000200004
Efficacy, safety, quality control, marketing and regulatory guidelines for herbal medicines (phytotherapeutic agents)
Abstract
This review highlights the current advances in knowledge about the safety, efficacy, quality control, marketing and regulatory aspects of botanical medicines. Phytotherapeutic agents are standardized herbal preparations consisting of complex mixtures of one or more plants which contain as active ingredients plant parts or plant material in the crude or processed state. A marked growth in the worldwide phytotherapeutic market has occurred over the last 15 years. For the European and USA markets alone, this will reach about $7 billion and $5 billion per annum, respectively, in 1999, and has thus attracted the interest of most large pharmaceutical companies. Insufficient data exist for most plants to guarantee their quality, efficacy and safety. The idea that herbal drugs are safe and free from side effects is false. Plants contain hundreds of constituents and some of them are very toxic, such as the most cytotoxic anti-cancer plant-derived drugs, digitalis and the pyrrolizidine alkaloids, etc. However, the adverse effects of phytotherapeutic agents are less frequent compared with synthetic drugs, but well-controlled clinical trials have now confirmed that such effects really exist. Several regulatory models for herbal medicines are currently available including prescription drugs, over-the-counter substances, traditional medicines and dietary supplements. Harmonization and improvement in the processes of regulation is needed, and the general tendency is to perpetuate the German Commission E experience, which combines scientific studies and traditional knowledge (monographs). Finally, the trend in the domestication, production and biotechnological studies and genetic improvement of medicinal plants, instead of the use of plants harvested in the wild, will offer great advantages, since it will be possible to obtain uniform and high quality raw materials which are fundamental to the efficacy and safety of herbal drugs.
Similar articles
-
Utility of alkaloids as chemical and biomarkers for quality, efficacy, and safety assessment of botanical ingredients.Phytomedicine. 2019 Feb 15;54:347-356. doi: 10.1016/j.phymed.2018.03.064. Epub 2018 Mar 28. Phytomedicine. 2019. PMID: 30837071 Review.
-
The legal framework governing the quality of (traditional) herbal medicinal products in the European Union.J Ethnopharmacol. 2014 Dec 2;158 Pt B:449-53. doi: 10.1016/j.jep.2014.07.044. Epub 2014 Jul 31. J Ethnopharmacol. 2014. PMID: 25086408
-
European legislation on herbal medicines: a look into the future.Drug Saf. 2008;31(5):428-31. doi: 10.2165/00002018-200831050-00009. Drug Saf. 2008. PMID: 18422385
-
Regulation of medicinal plants for public health--European community monographs on herbal substances.Planta Med. 2012 Aug;78(12):1311-6. doi: 10.1055/s-0031-1298578. Epub 2012 May 22. Planta Med. 2012. PMID: 22618374
-
Global harmonization of herbal health claims.J Nutr. 2001 Mar;131(3s):1120S-3S. doi: 10.1093/jn/131.3.1120S. J Nutr. 2001. PMID: 11238830 Review.
Cited by
-
Effectiveness of the Novel Herbal Medicine, KIOM-MA, and Its Bioconversion Product, KIOM-MA128, on the Treatment of Atopic Dermatitis.Evid Based Complement Alternat Med. 2012;2012:762918. doi: 10.1155/2012/762918. Epub 2012 Feb 1. Evid Based Complement Alternat Med. 2012. PMID: 22454683 Free PMC article.
-
Dynamics of medicinal plants knowledge and commerce in an urban ecosystem (Pernambuco, Northeast Brazil).Environ Monit Assess. 2011 Jul;178(1-4):179-202. doi: 10.1007/s10661-010-1681-3. Epub 2010 Sep 21. Environ Monit Assess. 2011. PMID: 20853190
-
The effects of long-term occupational exposure to dust from herbs.Int Arch Occup Environ Health. 2006 Feb;79(2):169-75. doi: 10.1007/s00420-005-0041-z. Epub 2005 Oct 11. Int Arch Occup Environ Health. 2006. PMID: 16217676
-
Trends in publication of evidence-based Traditional Iranian medicine in endocrinology and metabolic disorders.J Diabetes Metab Disord. 2013 Dec 19;12(1):49. doi: 10.1186/2251-6581-12-49. J Diabetes Metab Disord. 2013. PMID: 24355592 Free PMC article.
-
Priorities and Future Actions for an Effective Use of Phytotherapy in Livestock-Outputs from an Expert Workshop.Front Vet Sci. 2018 Jan 22;4:248. doi: 10.3389/fvets.2017.00248. eCollection 2017. Front Vet Sci. 2018. PMID: 29404346 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical